Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time Irradiation.

Jonas E Adolph Gudrun FleischhackSebastian TschirnerLydia RinkChristine DittesRuth MikaschPhilipp DammannMartin MynarekDenise Obrecht-SturmStefan RutkowskiBrigitte BisonMonika Warmuth-MetzTorsten PietschStefan M PfisterKristian W PajtlerTill MildeRolf-Dieter KortmannStefan Dietzsch Beate Timmermann Stephan Tippeltnull null

Published in: Cancers (2024)

RT2 could improve the median survival in a matched cohort but offered little benefit regarding long-term survival. In RT-naïve patients, CSI greatly improved their median and long-term survival.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
early stage
peritoneal dialysis
locally advanced
patient reported outcomes
free survival